The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 6, 2013, Pages 987-990

  Ahmad, Aquil ^a   Singhal, Usha ^a   Hossain, Mohd Mobark ^a   Islam, Najmul ^a   Rizvi, Imran ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Catalase; Essential hypertension; Glutathione peroxidase; Oxidative stress; Superoxide dismutase antihypertensive therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATALASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN REGULATION; ENZYME BLOOD LEVEL; ESSENTIAL HYPERTENSION; HUMAN; LIPID PEROXIDATION; MEAN ARTERIAL PRESSURE; OXIDATIVE STRESS; TREATMENT OUTCOME; UPREGULATION;

EID: 84878867846     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5829.3091     Document Type: Article

References (22)

1. Juranek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species--cause or consequence of tissue injury? Gen Physiol Biophys. 2005;24:263-78.
2. Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:23-8.
3. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42:1075-81.
4. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 2001;19:741-8.
5. Philpot J. Assay for MDA levels. Rad Res. 1963;3:55-80.
6. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
7. Paglia DE, Valentine WN. Studies on the quantitative characterization of erythrocyte glutathione peroxidise. J lab Clin Med. 1967;70:158-69.
8. McCord JM, Fridovich I. Superoxide dismutase an enzymic function for erythrocuprein hemocuprein. J Biol Chem. 1969;244:6049-55.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
10. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant rich diet relieves hypertension and reduces renal immune filteration in spontaneously hypertensive rats. Hypertension. 2003;41:341-6.
11. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, Sáez GT. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003;41:1096-101.
12. Kedziora-Kornatowska K, Czuczejko J, Pawluk H, Kornatowski T, Motyl J, Szadujkis-Szadurski L, et al. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett. 2004;9:635-41.
13. Simic DV, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A, Opacic M, Matic D, et al. Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension. J Hum Hypertens. 2006;20:149-55.
14. Nwanjo HU, Oze G, Okafor MC, Nwasu D, Nwankpa P. Oxidative stress and non enzymic antioxidant status in hypertensive patients in Nigeria. African Journal of Biotechnology. 2007;6:1681-4.
15. rd edn. CBs publishers and distributors. New Delhi.2002;545-555.
16. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002;23:360-6.
17. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-25.
18. Ferrari R, Fox K. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story. Drugs. 2009;69:265-77.
19. Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR. Combination of oral antioxidant supplementation reduces blood pressure. Clin Sci (Lond). 1997;92:361-5.
20. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33.
21. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long term effect of vit C supplementation on blood pressure. Hypertension. 2002;40:797-803.
22. Palumbo G, Avanzini F, Alli C, Roncaglioni MC, Ronchi E, Cristofari M, et al. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study. Am J Hypertens. 2000;13:564-7.